Adjuvant development

Investigating the contribution of adjuvants to vaccine protection

The next generation of human vaccine adjuvants to improve vaccine efficacy are only now emerging; however their widespread use is hindered by a limited understanding of mode of action and safety.

New adjuvants will be assessed in-depth for immunological function and enhancement of vaccine-induced protective immunity for viral and antibiotic resistant bacterial pathogens. This information will allow adjuvants to be ‘matched’ to existing and novel pathogens based on the immune-activating profile required.